Ergocalciferol Capsules and Tablets and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Ergocalciferol Capsules and Tablets and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ergocalciferol
Brand name: Calcidol, Calciferol, Drisdol, Vitamin D2
Synonyms: Ergocalciferol
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ergocalciferol Capsules and Tablets-Insulin glargine, recombinant Subcutaneous
- Ergocalciferol Capsules and Tablets-Insulin glulisine
- Ergocalciferol Capsules and Tablets-Insulin Glulisine (Cartridges and Pens)
- Ergocalciferol Capsules and Tablets-Insulin Glulisine (Vials)
- Ergocalciferol Capsules and Tablets-Insulin glulisine Subcutaneous
- Ergocalciferol Capsules and Tablets-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Ergocalciferol Solution
- Insulin glargine and lixisenatide Subcutaneous-Ergoloid
- Insulin glargine and lixisenatide Subcutaneous-Ergoloid mesylates
- Insulin glargine and lixisenatide Subcutaneous-Ergoloid mesylates Oral, Sublingual
- Insulin glargine and lixisenatide Subcutaneous-Ergoloid Tablets
- Insulin glargine and lixisenatide Subcutaneous-Ergomar